Advanced process control market is projected to grow from $5.2 billion in 2025 to $11.8 billion by 2035, registering a CAGR of 8.5% during the forecast period (2026–2035). The market growth is strongly driven by increasing demand for energy efficiency and process optimization across industrial sectors. According to the International Energy Agency, the industrial sector accounts for nearly 37% of global energy consumption, highlighting the critical need for technologies that improve operational efficiency. APC solutions such as Model Predictive Control (MPC) and Real-Time Optimization (RTO) enable industries to reduce energy consumption, improve yield, and enhance process stability, making them essential for modern industrial operations.

Acne therapeutics market was valued at $8.1 billion in 2025 and is projected to reach $12.9 billion by 2035, growing at a CAGR of 4.8% during 2026 to 2035. The market expansion is primarily driven by the increasing global burden of acne and other dermatological conditions, particularly among adolescents and young adults. According to the World Health Organization, skin diseases collectively account for a substantial share of non-fatal disease burden worldwide, with dermatological conditions ranking among the leading causes of disability-adjusted life years (DALYs). In addition, the U.S. National Institutes of Health reports that acne affects up to 50 million people annually in the United States, indicating a significant and recurring treatment demand across developed markets.

Selective Laser Sintering (SLS) technology market is projected to grow from $1.4 billion in 2025 to $3.1 billion by 2035, expanding at a CAGR of 8.2% during the forecast period (2026–2035). The market growth is primarily driven by increasing adoption of additive manufacturing technologies for producing lightweight, high-performance components across industries such as aerospace, automotive, and healthcare.

Rheumatoid arthritis market was valued at $54 billion in 2025 and is projected to reach $90 billion by 2035, growing at a CAGR of 5.2% during the forecast period (2026–2035). The rising global burden of autoimmune diseases is significantly strengthening demand for advanced rheumatoid arthritis therapeutics. Rheumatoid arthritis (RA), a chronic inflammatory disorder, continues to increase in prevalence due to aging populations, lifestyle risk factors, and improved diagnostic capabilities. The growing adoption of biologic and targeted synthetic therapies is transforming treatment outcomes and supporting long-term disease management.

Retinal disorders treatment market is projected to grow from $23.7 billion in 2025 to $44.5 billion by 2035, expanding at a CAGR of 6.5% during the forecast period (2026–2035). The market growth is primarily driven by the rising prevalence of vision impairment and retinal diseases, alongside advancements in biologics and gene-based therapies.

Rainwater harvesting market is projected to grow from $3.05 billion in 2025 to $5.56 billion by 2035, registering a CAGR of 6.2% during the forecast period (2026–2035). The market growth is strongly driven by increasing global water scarcity and rising demand for sustainable water management solutions across residential, commercial, and industrial sectors.

Sulphonamides market is projected to grow from $1.4 billion in 2025 to $2.2 billion by 2035, expanding at a CAGR of 4.6% during the forecast period. increasing prevalence of bacterial infections and the continued demand for cost-effective antimicrobial treatments are key factors driving market growth. Sulphonamides, known for their broad-spectrum antibacterial properties, remain widely used in both human and veterinary medicine.

Pregnancy care products market was valued at $2.65 billion in 2025 and is projected to reach $4.35 billion by 2035, growing at a CAGR of 5.1% during the forecast period (2026–2035). The increasing focus on maternal health and wellness, supported by rising awareness regarding prenatal and postnatal skincare, is significantly driving demand for pregnancy care products globally. Governments and healthcare organizations are actively promoting maternal health programs, encouraging the adoption of safe, dermatologically tested, and chemical-free personal care products during pregnancy. These factors are accelerating the adoption of stretch mark minimizers, breast care products, and intimate hygiene solutions across both developed and emerging economies.

Neuropathic pain treatment market was valued at $10.9 billion in 2025 and is projected to reach $19.2 billion by 2035, growing at a CAGR of 5.8% during the forecast period (2026–2035). The increasing global burden of chronic diseases, particularly diabetes and cancer, is significantly driving demand for neuropathic pain therapies. Neuropathic pain arises from nerve damage and is often chronic and difficult to treat, requiring long-term therapeutic management through pharmacological and non-pharmacological approaches. The growing aging population, coupled with the rising prevalence of nerve-related disorders, is further accelerating the demand for effective treatment solutions.

Macular degeneration treatment market was valued at $18.8 billion in 2025 and is projected to reach $33.7 billion by 2035, growing at a CAGR of 6.0% during the forecast period (2026–2035). The increasing global burden of age-related vision impairment, particularly among the aging population, is significantly driving demand for effective macular degeneration treatments. According to data from the National Institutes of Health (NIH), approximately 2.2 billion people globally suffer from vision impairment or blindness, with age-related macular degeneration (AMD) being a leading cause among individuals aged 60 years and above. This rising prevalence is accelerating the adoption of advanced therapeutic interventions, including anti-VEGF therapies and emerging biologics, thereby strengthening market growth.